217 related articles for article (PubMed ID: 20022991)
1. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
[TBL] [Abstract][Full Text] [Related]
2. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
Sarfati J; Dodé C; Young J
Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
[TBL] [Abstract][Full Text] [Related]
3. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
[TBL] [Abstract][Full Text] [Related]
4. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
[TBL] [Abstract][Full Text] [Related]
5. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
7. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
[TBL] [Abstract][Full Text] [Related]
8. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
Hardelin JP; Dodé C
Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
[TBL] [Abstract][Full Text] [Related]
9. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
[TBL] [Abstract][Full Text] [Related]
10. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
[TBL] [Abstract][Full Text] [Related]
11. The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.
Martin C; Balasubramanian R; Dwyer AA; Au MG; Sidis Y; Kaiser UB; Seminara SB; Pitteloud N; Zhou QY; Crowley WF
Endocr Rev; 2011 Apr; 32(2):225-46. PubMed ID: 21037178
[TBL] [Abstract][Full Text] [Related]
12. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations.
Salenave S; Chanson P; Bry H; Pugeat M; Cabrol S; Carel JC; Murat A; Lecomte P; Brailly S; Hardelin JP; Dodé C; Young J
J Clin Endocrinol Metab; 2008 Mar; 93(3):758-63. PubMed ID: 18160472
[TBL] [Abstract][Full Text] [Related]
13. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
14. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
[TBL] [Abstract][Full Text] [Related]
15. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
16. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
[TBL] [Abstract][Full Text] [Related]
17. The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.
Abreu AP; Kaiser UB; Latronico AC
Neuroendocrinology; 2010; 91(4):283-90. PubMed ID: 20502053
[TBL] [Abstract][Full Text] [Related]
18. PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption.
Reynaud R; Jayakody SA; Monnier C; Saveanu A; Bouligand J; Guedj AM; Simonin G; Lecomte P; Barlier A; Rondard P; Martinez-Barbera JP; Guiochon-Mantel A; Brue T
J Clin Endocrinol Metab; 2012 Jun; 97(6):E1068-73. PubMed ID: 22466334
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of prokineticin 2 in the control of energy metabolism.
Magnan C; Migrenne-Li S
Biochimie; 2021 Jul; 186():73-81. PubMed ID: 33932486
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
Martinez-Mayer J; Perez-Millan MI
Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
